The Application Notebook
Heating is a common and essential requirement in most biopharmaceutical production methods. Chitosan is an amino polysaccharide obtained by alkaline deacetylation of naturally abundant chitin.
Heating is a common and essential requirement in most biopharmaceutical production methods. Chitosan is an amino polysaccharide obtained by alkaline deacetylation of naturally abundant chitin. It is known as a potentially beneficial material in many pharmaceutical applications such as tissue engineering, drug delivery, cell encapsulation and medical devices. In this study, we investigated the effect of high-temperature heating on chitosan molecular weights, the most important characteristic of chitosan.
In this study, a GPC-MALS system was used to determine molecular weight. The system employs a Shimadzu solvent delivery system. The solvent (0.2 M acetic acid/0.1 M sodium acetate) was filtered and degassed through 0.22 µm nylon filter under vacumm and delivered to the system. The flow rate was set to be 0.5 mL/min.
Figure 1: Results from chitosan not heated.
Waters Ultrahydrogel 250 and Ultrahydrogel 2000 with the separation range from 103 to 8 × 104 and from 50 × 104 to 7 × 106 kDa respectively were used. The columns were located in a Shimadzu column oven. System temperature was set to be 35 °C. Chitosan solution samples were diluted to a concentration of 2 mg/mL using the solvent, then filtered through 0.2 µm PVDF filters and injected into the GPC columns with a manual Rheodyne syringe injector equipped with a 100 µL sample loop.
Figure 2: Results from chitosan heated.
Two detectors included the Wyatt Optilab (AUX1) and a Shimadzu UV/vis detector (AUX2) operated at 280 nm. The Wyatt DAWN EOS (enhanced optical system).
A value of 0.180 mL/g was used for the refractive index increment (dn/dc). The data were collected and analysed by the ASTRA software. The molecular weight of non-treated chitosan was found to be (1.44 ± 0.009) × 105 g/mol. Chitosan which was heated at 85 °C in an oven for 9 hours had a molecular weight of (7.903 ± 0.038) × 104 g/mol.
High temperature heating, therefore, caused the decrease in the molecular weight of chitosan.
This note was graciously submitted by Hang Thu Ta, Department of Chemical and Biomolecular Engineering, The University of Melbourne, Australia.
DAWN, miniDAWN, ASTRA, Optilab and the Wyatt Technology logo are registered trademarks of Wyatt Technology Corporation. ©2009 Wyatt Technology Corporation 9/11/09
Wyatt Technology Corporation
6300 Hollister Avenue, Santa Barbara, California 93117, USA
tel. +1 805 681 9009 fax +1 805 681 0123
E-mail: info@wyatt.com
Website: www.wyatt.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.